Pharmacokinetic profile after multiple deltoid or gluteal intramuscular injections of paliperidone palmitate in patients with schizophrenia

Publisher： John Wiley & Sons Inc

E-ISSN： 2160-7648|4|4|270-278

ISSN： 2160-763X

Source： Clinical Pharmacology In Drug Development, Vol.4, Iss.4, 2015-07, pp. : 270-278

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Population Pharmacokinetics of Intramuscular Paliperidone Palmitate in Patients with Schizophrenia: A Novel Once-Monthly, Long-Acting Formulation of an Atypical Antipsychotic

By Samtani Mahesh N.  

Clinical Pharmacokinetics, Vol. 48, Iss. 9, 2009-09 ,pp. : 585-600

Adis International

Access to resources Recommend Favorite

Intramuscular Paliperidone Palmitate

By Hoy Sheridan M.   Scott Lesley J.   Keating Gillian M.  

CNS Drugs, Vol. 24, Iss. 3, 2010-03 ,pp. : 227-244

Adis International

Access to resources Recommend Favorite

Intramuscular prolonged-release paliperidone palmitate: a guide to its use in schizophrenia

By  

Drugs & Therapy Perspectives, Vol. 27, Iss. 11, 2011-11 ,pp. : 1-5

Adis International

Access to resources Recommend Favorite

Extended-Release Intramuscular Paliperidone Palmitate: A Review of its Use in the Treatment of Schizophrenia

By Carter Natalie J.  

Drugs, Vol. 72, Iss. 8, 2012-05 ,pp. : 1137-1160

Adis International

Access to resources Recommend Favorite

Onset and persistence of efficacy by symptom domain with long-acting injectable paliperidone palmitate in patients with schizophrenia

By Alphs Larry   Bossie Cynthia A   Fu Dong-Jing   Ma Yi-Wen   Kern Sliwa Jennifer  

Expert Opinion on Pharmacotherapy, Vol. 15, Iss. 7, 2014-05 ,pp. : 1029-1042

Informa Healthcare

Access to resources Recommend Favorite